Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 51c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 51c

Jazz Pharmaceuticals (JAZZ) PT Raised to $208 at BMO Capital

May 8, 2019 7:48 AM EDT

BMO Capital analyst Gary Nachman raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $208.00 (from $206.00) while maintaining a Outperform rating.

Nachman commented, "JAZZ delivered strong, high-quality 1Q results with impressive beats on both top and bottom lines while maintaining robust spending... More